Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-24T06:26:32.315Z Has data issue: false hasContentIssue false

Evaluating the implementation of a multidisciplinary lifestyle intervention for people with severe mental illness in sheltered housing: effectiveness-implementation hybrid randomised controlled trial

Published online by Cambridge University Press:  22 November 2022

Marij M. C. Smit
Affiliation:
GGz Centraal, Amersfoort, The Netherlands; and Faculty of Social and Behavioural Sciences, Utrecht University, Utrecht, The Netherlands
Elze de Waal
Affiliation:
GGz Centraal, Amersfoort, The Netherlands; and Faculty of Social and Behavioural Sciences, University of Amsterdam, Amsterdam, The Netherlands
Diederik E. Tenback
Affiliation:
Centre for Transcultural Psychiatry (CTP)Veldzicht, Balkbrug, The Netherlands
Jeroen Deenik*
Affiliation:
GGz Centraal, Amersfoort, The Netherlands; and School for Mental Health and Neuroscience, Maastricht University, Maastricht,The Netherlands
*
Correspondence: Jeroen Deenik. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Background

Lifestyle interventions can improve health-related outcomes for people with severe mental illness (SMI), but few studies evaluate this potential in everyday settings. After a successful approach in routine inpatient mental healthcare (MULTI), we sought to replicate this multidisciplinary lifestyle-enhancing support in people with SMI living in sheltered housing (MULTI_sh).

Aims

To evaluate the effectiveness and implementation of MULTI_sh (trial registration: NCT03157557).

Method

In an effectiveness-implementation hybrid cluster-randomised controlled trial, six municipalities with sheltered housing facilities in The Netherlands were randomly assigned to MULTI_sh (n = 3) or treatment as usual (TAU, n = 3). After 12 months, we evaluated effects on metabolic health, sedentary behaviour/physical activity (ActiGraph GT3X+), quality of life (EuroQol 5D, WHOQoL-Bref) and psychopathology (Brief Psychiatric Rating Scale Expanded Version) using multiple regression, adjusting for baseline values and municipalities (intention to treat and per protocol). In addition, implementation fidelity and barriers/facilitators were evaluated (Measurement Instrument for Determinants of Innovation).

Results

Of 177 eligible patients, 74 (42%) could be included in the analyses. Health outcomes did not substantially improve with MULTI_sh (n = 45) compared with TAU (n = 29). MULTI_sh was not implemented as intended. Most patients and all healthcare professionals believed that patients’ lifestyle should be part of treatment, but implementation was primarily (in)directly hindered by organisational factors (e.g. staff shortages, complexity of participation, lack of time and difficulty getting patients involved).

Conclusions

MULTI_sh was not implemented as intended and no clinical health improvements were found. Organisations are decisive in the success or failure of the implementation of lifestyle interventions for people with SMI. More intensive implementation strategies on this level are warranted in sheltered housing.

Type
Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © GGz Centraal, 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists

Over recent decades, the up to 20 years shortened life expectancy of people with severe mental illness (SMI, e.g. schizophrenia-spectrum, major depressive or bipolar disorder) compared with the general population has remained similar and is mainly caused by comorbid physical conditions, including cardiometabolic diseases.Reference Firth, Siddiqi, Koyanagi, Siskind, Rosenbaum and Galletly1Reference Taipale, Tanskanen, Mehtälä, Vattulainen, Correll and Tiihonen3 These conditions have a combination of interacting risk factors, including immunometabolic dysregulation,Reference Mackin, Bishop, Watkinson, Gallagher and Ferrier4,Reference Lopresti and Drummond5 genetic vulnerability,Reference Amare, Schubert, Klingler-Hoffmann, Cohen-Woods and Baune6 side-effects of antipsychotic medication,Reference Verhaegen and Van Gaal7 lower use of somatic careReference Swildens, Termorshuizen, de Ridder, Smeets and Engelhard8 and an unhealthy lifestyle (i.e. sedentary behaviour, low levels of physical activity, smoking and dietary risks such as malnutrition and low intake of fruit and vegetables).Reference Firth, Siddiqi, Koyanagi, Siskind, Rosenbaum and Galletly1

A growing number of studies focusing on lifestyle interventions in people with SMI show positive improvements in physical and mental health, for example by increasing physical activity and/or improving poor dietary habits.Reference Vancampfort, Firth, Correll, Solmi, Siskind and De Hert9Reference Taylor, Lindson, Farley, Leinberger-Jabari, Sawyer and te Water Naudé13 However, there is limited evidence regarding the maintenance and long-term health benefits of lifestyle interventions, especially in naturalistic settings.Reference Stubbs, Vancampfort, Hallgren, Firth, Veronese and Solmi12,Reference Jakobsen, Speyer, Norgaard, Karlsen, Birk and Hjorthoj14,Reference Naslund, Whiteman, McHugo, Aschbrenner, Marsch and Bartels15 Such evaluations (i.e. effectiveness studies) give a more representative view on effect sizes in everyday healthcare, which may be reduced compared with the ideal conditions in the research context of efficacy studies. Parallel to this, more implementation studies are needed to gain insight into factors influencing the intended implementation of interventions.Reference Curran, Bauer, Mittman, Pyne and Stetler16,Reference Deenik, Czosnek, Teasdale, Stubbs, Firth and Schuch17 This informs interpretations of the effects found and suggests strategies to target barriers, thus improving the implementation of the intervention.Reference Powell, Waltz, Chinman, Damschroder, Smith and Matthieu18 The concurrent running of effectiveness and implementation studies speeds up the translation of research into effects on everyday healthcare.Reference Curran, Bauer, Mittman, Pyne and Stetler16

Recently, a multidisciplinary lifestyle-enhancing treatment for in-patients with SMI called MULTI was evaluated 18 months after implementation. MULTI was developed after finding that an integrated approach seemed needed to translate positive attitudes and self-efficacy into behavioural change in the context of the theory of planned behaviour.Reference Deenik, Kruisdijk, Tenback, Braakman-Jansen, Taal and Hopman-Rock19 MULTI focused on overall physical activation and sustainable behavioural change using daily structure, mainly targeting sedentary behaviour and healthy nutrition and eating habits. The study found improvements in physical activity, metabolic risk factors (e.g. weight, abdominal girth, high-density lipoprotein (HDL) cholesterol), medication use and psychosocial functioning compared with treatment as usual (TAU).Reference Deenik, Tenback, Tak, Rutters, Hendriksen and van Harten20Reference Deenik, Tenback, Tak, Hendriksen and van Harten22 Both patients and healthcare professionals were optimistic about the intervention and their role in it.Reference Deenik, Tenback, Tak, Blanson Henkemans, Rosenbaum and Hendriksen23 This is in line with recent studies showing that a multicomponent approach (e.g. physical activity, attention to dietary risks, psychoeducation), multidisciplinary collaboration and engaging healthcare professionals are essential in encouraging a healthy lifestyle in SMI.Reference Firth, Siddiqi, Koyanagi, Siskind, Rosenbaum and Galletly1,Reference Firth, Solmi, Wootton, Vancampfort, Schuch and Hoare24,Reference Lederman, Suetani, Stanton, Chapman, Korman and Rosenbaum25

In the context of implementation science, studying the application of a successful intervention in another setting is considered essential when exploring its potential for dissemination and broader adoption.Reference Chambers and Norton26 Sheltered housing facilities for people with SMI are often closely connected to in-patient facilities (e.g. before or after hospital admission) and thus are a logical first setting to extend MULTI to. People with SMI in sheltered housing live more independently and face barriers to adhering to a healthy lifestyle, such as the symptoms of SMI and medication-related side-effects (i.e. metabolic syndrome, sedation and movement disorder).Reference McDevitt, Snyder, Miller and Wilbur27 Also, fear of discrimination and reliance on healthcare professionals to plan and initiate rehabilitation programme activities play a role.Reference McDevitt, Snyder, Miller and Wilbur27

Therefore, we aimed to investigate whether a lifestyle programme based on MULTI (multidisciplinary lifestyle-enhancing support for patients living in sheltered housing, MULTI_sh) could help to improve the lifestyle and, thereby, the health status of people with SMI living in such facilities. In an effectiveness-implementation hybrid randomised controlled trial,Reference Curran, Bauer, Mittman, Pyne and Stetler16 we aimed to evaluate:

  1. (a) the effectiveness of MULTI_sh on both physical and mental health

  2. (b) whether MULTI_sh was implemented as intended and to identify associated implementation barriers and facilitators to expedite the translation of research findings into routine care.

Method

Design

We used an open-label effectiveness-implementation type-1 hybrid cluster-randomised controlled trial design, testing the effectiveness of MULTI_sh on health-related outcomes while observing and gathering information on implementation.Reference Curran, Bauer, Mittman, Pyne and Stetler16 The study was conducted in the sheltered housing facilities of GGz Centraal (The Netherlands). After baseline measurements (July–October 2017), MULTI_sh was implemented in three sheltered housing locations in April 2018. Follow-up measurements took place 12 months after implementation (March–May 2019). Data on patients were collected from routine screening data (demographic/metabolic health parameters), actigraphy measurement (sedentary behaviour/physical activity) and questionnaires that were completed through semi-structured interviews by trained research assistants (psychopathology, quality of life (QoL), programme implementation fidelity and barriers/facilitators). The 12-month evaluation and extra metabolic health parameters (weight, blood pressure and HbA1c), psychopathology and implementation factors were part of an expansion of the originally initiated 6-month evaluation after it was found to be feasible and contributed to the study objectives. Data from healthcare professionals on the implementation of MULTI_sh were collected via an online version of the questionnaire using a unique email link. In addition, three reminder emails were sent at 2-week intervals to all non-responders. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving patients were approved by the Medical Ethical Committee of the Isala Academy (case 170403) and registered at Clinicaltrials.gov (NCT03157557). All participants gave written informed consent.

Study population

The cohort consisted of 177 individuals (≥18 years) with SMI (schizophrenia spectrum, major depressive or bipolar disorder) living in sheltered housing facilities of GGz Centraal within the Veluwe and Veluwe Valley region of The Netherlands. There were no exclusion criteria for receiving MULTI_sh as it was developed for people with SMI in sheltered housing in which activities were tailored to individual needs and interests (see the paragraph below describing the intervention). For measurements, individuals were included if they lived in one of the six sheltered housing facilities and gave informed consent. They were excluded if they refused measurements or if there was any risk that the measurements could cause (further) worsening of psychiatric symptoms, as evaluated by their respective care team and physician.

Interventions

The purpose of MULTI_sh was holistic lifestyle change with a focus on decreasing sedentary behaviour, increasing physical activity and improving dietary habits. The intervention consisted of improving daily structure by getting up on time, having joint meals and having an active daily programme consisting of work-related activities (e.g. supporting functions in garden maintenance), sports-related activities (e.g. walking), psychoeducation (e.g. regarding the side-effects of medication) and training in daily living skills (e.g. cooking). Additionally, if necessary, existing policies were reviewed and adjusted (e.g. about eating together and getting groceries by foot/cycle or car). Given the heterogeneity in illness severity, capabilities and interests in the individuals and in the sheltered housing facilities as a whole, the content and intensity of the day-to-day programme were tailored to the particular sheltered housing facility and individual patients with the aim of achieving sustainable change. In line with MULTI in in-patient facilities,Reference Deenik, Tenback, Tak, Blanson Henkemans, Rosenbaum and Hendriksen23 MULTI_sh was based on a ‘change from within’ principle, meaning that the aim was to change patients’ programmes and the team culture within the staffing and resources available in routine care. At each intervention site, a mental healthcare professional with secondary or higher vocational education in mental healthcare (e.g. nurse or social worker) was appointed to coordinate the improvement of daily structures and activity programme in cooperation with the team and by connecting with qualified experts (e.g. exercise professionals and dietitians in the community) to support and supervise this.

Participants who received TAU continued their regular treatment, mainly consisting of a less structured day programme and medication, excluding any extra support in lifestyle interventions or adjustments.

Outcomes

Metabolic health

Metabolic health was the primary outcome measure, represented by abdominal girth measured to the nearest 0.1 cm, on bare skin, across the umbilicus, halfway between the iliac crest and lowest rib in a standing position. Additionally, data on weight (without shoes in an upright position to the nearest 0.1 kg), blood pressure, triglycerides, fasting glucose, HbA1c and total and HDL cholesterol were part of routine somatic screening.

Sedentary behaviour and physical activity

Sedentary behaviour and physical activity were measured using the triaxial ActiGraph GT3X+ accelerometer. Detailed procedures and settings used for the baseline and follow-up measurements are described elsewhere.Reference Deenik, Tenback, Tak, Rutters, Hendriksen and van Harten20,Reference Kruisdijk, Deenik, Tenback, Tak, Beekman and van Harten28 The ActiGraph was worn on the right hip for five consecutive days (Wednesday 09.00 h until Sunday 23.59 h) except for activities involving water and sleeping. Each data-set had the same time frame of 09.00–22.00 h to make the data comparable between participants. To avoid significant drop-out of data, a wear time of a minimum of 6 h a day for at least 3 days was the criterion for valid measurement.Reference Kruisdijk, Deenik, Tenback, Tak, Beekman and van Harten28 Data were analysed using the ActiLife 6.8.0 software (www.actigraph.nl) and converted into average total activity counts per hour (TAC/h). TAC/h was standardised to facilitate interpretation. The GT3X+ has a high inter- and intra-instrumental reliability and validity.Reference Jarrett, Fitzgerald and Routen29,Reference Gatti, Stratford, Brenneman and Maly30

Psychopathology

The Dutch version of the Brief Psychiatric Rating Scale Expanded Version (BPRS-E)Reference Dingemans, Frohndewinter, Bleeker and Rathod31 was used to evaluate general psychopathology. The BPRS-E consists of 24 items measuring the severity of psychopathology, including schizophrenia and related psychotic disorders. Items are scored from 1 (not present) to 7 (very serious) and divided into four subdomains: manic arousal/disorganisation, depression/anxiety, positive symptoms and negative symptoms. The BPRS has been found to be sufficiently valid and reliable.Reference Kopelowicz, Ventura, Liberman and Mintz32

Quality of life

Quality of life (QoL) was assessed using the Dutch versions of the EuroQol 5D (EQ-5D)Reference Williams33 and domains of the World Health Organization Quality of Life Brief Version (WHOQOL-Bref).Reference de Vries and van Heck34 The EQ-5D is a simple generic questionnaire measuring five dimensions of health (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) rated from 1 (no problems) to 3 (extreme problems) and has a reasonable validity, reliability and feasibility in people with schizophrenia.Reference Konig, Roick and Angermeyer35,Reference Pitkanen, Valimaki, Endicott, Katajisto, Luukkaala and Koivunen36 The WHOQOL-Bref contains 24 items distinguishing physical, psychological, social and environmental QoL. Items were scored from 1 (not at all/very dissatisfied/very poor/never) to 5 (completely/very satisfied/very good/always) and transformed into domain scores ranging from 4 to 20 according to WHO guidelines.37 The WHOQOL-Bref has good reliability, content and construct validity, and sensitivity for assessing QoL in psychiatric patients in generalReference Trompenaars, Masthoff, Heck, Hodiamont and Vries38 and specifically patients with schizophrenia.Reference Herrman, Hawthorne and Thomas39,Reference Mas-Exposito, Amador-Campos, Gomez-Benito and Lalucat-Jo40

Implementation

Implementation fidelity (i.e. the extent to which the intervention was implemented as intended, measured according to a predefined protocol)Reference Glasgow, Harden, Gaglio, Rabin, Smith and Porter41 and barriers and facilitators were measured using the Measurement Instrument for Determinants of Innovation (MIDI).Reference Fleuren, Paulussen, Van Dommelen and Van Buuren42 The MIDI comprises four subscales, measuring 29 determinants for implementation related to the intervention itself (n = 7), the users (healthcare professionals/patients, n = 11), the organisation (n = 10) and sociopolitical context (n = 1) on a five-point scale (totally disagree–totally agree). The questionnaire was used in the previous MULTI study in in-patient facilities and a report for that study gives detailed procedures.Reference Deenik, Tenback, Tak, Blanson Henkemans, Rosenbaum and Hendriksen23 According to the MIDI instruction guide, questions were tailored to the context of sheltered housing facilities (e.g. available disciplines in the context of social support). For patients, we limited the number of items on this questionnaire to those relevant from their perspective, to increase the feasibility and prevent unnecessary burden. As a pragmatic proxy of implementation fidelity, we used the descriptive norm determinant (i.e. how well colleagues implemented MULTI_sh), which was asked in relation to the predefined description of MULTI_sh.

Sample size

To calculate the sample size, we used the effect size of abdominal girth decrease in the previous intervention study (Cohen's d = 0.51 cm)Reference Deenik, Tenback, Tak, Rutters, Hendriksen and van Harten20 in a similar multiple regression analysis corrected for baseline values on age, diagnosis and illness severity. To detect the same effect in the current study with a minimum 80% power as a benchmark for a fair test, a 5% significance level and an expected response rate of 73% based on previous baseline measurements in in-patients with SMI,Reference Kruisdijk, Deenik, Tenback, Tak, Beekman and van Harten28 a sample size of 168 patients was required (two groups of 84).

Randomisation and masking

Cluster randomisation was carried out at the level of municipalities (n = 6) by an independent research assistant. To ensure equal numbers in both conditions, municipalities were paired based on their number of inhabitants in the sheltered housing facilities. One municipality out of each pair was randomly assigned to receive the intervention. The other municipality out of each pair continued to receive TAU. Owing to the nature of the intervention, masking (blinding) was not possible.

Statistical analysis

Data analyses were performed using SPSS 25.0 for Windows and interpreted on a 5% significance level. Differences in patient and disease characteristics between the MULTI_sh and TAU groups were analysed using independent t-tests (continuous variables) and χ² statistics (dichotomous variables). Participants whose change score for one measurement was missing were excluded from the analysis for that particular variable. Continuous variables were examined for normality, homogeneity and linearity as assumptions for t-tests and linear regression analyses by visual inspection of distributions, Q–Q and scatterplots and by comparing means with medians and standard deviations. If assumptions were violated, non-parametric tests were executed.

Multiple regression analyses were used to evaluate changes in outcomes between the MULTI_sh and TAU groups. Change scores on the outcome variables (T 2T 1) were regressed on the treatment variable (model 1) and adjusted for the baseline value and different municipalities to account for potential regression to the mean and clustering within other sheltered housing locations. All analyses were primarily based on intention to treat. Additionally, per-protocol analyses were conducted.

To evaluate the MIDI determinants, we used the means and standard deviations, as well as the score per subscale, after recoding negatively stated items. Items to which ≥20% of the healthcare professionals and patients responded negatively (corresponding to ‘totally disagree/disagree’, score <3) were considered barriers and those to which ≥80% of healthcare professionals and patients responded positively (corresponding to ‘agree/totally agree’, score >3) were considered facilitators in the implementation of MULTI_sh. Proportions of score 3 were reported as neutral. A detailed description of the statistical analyses has been given elsewhere.Reference Deenik, Tenback, Tak, Blanson Henkemans, Rosenbaum and Hendriksen23

Results

As shown in Fig. 1, out of 177 eligible patients, 74 (42%) could eventually be included in analyses (i.e. both baseline and follow-up measurements of at least one outcome available). Of the 104 patients who gave informed consent to participate in the study, 30 dropped out for analyses. They did not significantly differ in age, gender, diagnosis or baseline illness severity compared with patients included in the analyses. Of the patients included in the analyses, there were also no significant differences in patient and illness characteristics between participants in the MULTI_sh (n = 45) and the TAU groups (n = 29). The support of the sheltered housing healthcare professionals was limited for four patients because those patients were not around for most of the study time. Consequently, the per-protocol analyses were conducted for 41 and 29 participants in intervention and control conditions respectively. No adverse events were reported.

Fig. 1 Flowchart including the number of participants per outcome and reasons for incomplete data on baseline and follow-up.

MULTI_sh, multidisciplinary lifestyle-enhancing treatment for people with severe mental illness living in sheltered housing; TAU, treatment as usual; lab, laboratory tests. aFour patients did not receive support by the sheltered housing teams for most of the study time because they were not around (e.g. partly lived elsewhere). bNumber of participants for whom both baseline and follow-up measurements of at least one outcome were available.

Of the 41 patients still involved in MULTI_sh at follow-up, 39 completed the semi-structured interview evaluating its implementation. Two dropped out because they refused or because the majority of the interview could not be completed. Of the 36 available healthcare professionals, 4 did not respond and 6 ended the questionnaire after a few items, resulting in responses from 26 participants for analyses.

Health outcomes

There was little change in abdominal girth and other metabolic health outcomes in either the MULTI_sh or TAU groups (Table 1). Similarly, little change was observed in both groups for sedentary behaviour and physical activity, psychopathology and QoL. Accordingly, multiple regression showed no clinically and statistically significant between-group effects for any health outcomes. The largest effects in adjusted regression, found for psychological QoL (B = 1.42, β = 0.28, 95% CI −0.14 to 2.98), total activity (B = 0.39, β = 0.27, 95% CI −0.17 to 0.94) and sedentary behaviour (B = −3.42, β = 0.27, 95% CI −7.31 to 0.48), remained relatively small (supplementary Table 1, available at https://dx.doi.org/10.1192/bjo.2022.600). Per-protocol analyses resulted in different, statistically significant outcomes only for psychological QoL in favour of MULTI_sh (B = 1.59, β = 0.36, 95% CI 0.22–2.97, P = 0.02).

Table 1 Baseline characteristics and baseline and follow-up measurements of participants on metabolic health, sedentary behaviour and physical activity, psychopathology and quality of life (n = 74)

MULTI_sh, multidisciplinary lifestyle-enhancing treatment for patients with severe mental illness living in sheltered housing; TAU, treatment as usual; BPRS-E, Brief Psychiatric Rating Scale Expanded Version; TAC/h, total activity counts per hour; EQ-5D, EuroQol five-dimension questionnaire; WHOQOL-Bref, World Health Organization Quality of Life Brief Version.

a. n = 44 for MULTI_sh and n = 29 for TAU, owing to missing diagnostic data.

b. n = 45 for MULTI_sh and n = 27 for TAU, owing to missing abdominal girth data.

c. n = 45 for MULTI_sh and n = 29 for TAU, owing to missing weight data.

d. n = 38 for MULTI_sh and n = 24 for TAU, owing to missing triglycerides and HDL cholesterol data.

e. n = 37 for MULTI_sh and n = 26 for TAU, owing to missing fasting glucose data.

f. n = 33 for MULTI_sh and n = 24 for TAU, owing to missing HbA1c data.

g. n = 39 for MULTI_sh and n = 24 for TAU, owing to insufficient wear time of the accelerometer.

Implementation

Table 2 shows the participant characteristics regarding the analysed implementation determinants. The question serving as a proxy for fidelity (descriptive norm) was answered by 26 healthcare professionals, of whom 35% (n = 9) indicated that half or less than half of their colleagues carried out MULTI_sh as intended. Of the patients who completed the MIDI interview (n = 39), ten answered that they could not correctly assess the question because their daily activity programme had not changed and/or they were not familiar with the programme as intended. Of the patients who did answer (n = 29), the majority (n = 15, 52%) estimated that less than half of the team carried out the programme as intended.

Table 2 Participant characteristics and scores for implementation determinants concerning MULTI_sh, healthcare professionals/patients and the organisation, with percentages for negative, neutral and positive responsesa

MULTI_sh, multidisciplinary lifestyle-enhancing treatment for patients with severe mental illness living in sheltered housing; neg., negative response (score <3); neu., neutral response (score 3); pos., positive response (score >3). Reported barriers (≥20% negative response) and facilitators (≥ 80% positive response) are shown in bold.

a. Scores could range from 1 to 5 unless noted otherwise in parentheses, and higher mean scores reflect a more positive contribution to the implementation of MULTI_sh.

b. Anxiety disorder (n = 1), delirium, dementia, and amnestic and other cognitive disorders (n = 1), alcohol-related disorders (n = 1), somatoform disorders (n = 1).

c. n = 35 for patients, owing to missing data.

d. n = 34 for patients, owing to missing data.

e. n = 36 for patients, owing to missing data.

f. n = 33 for patients, owing to missing data.

g. n = 29 for patients, owing to missing data; calculated to negative (scores of 1–3), neutral (4) and positive (5–7).

h. Calculated to negative (scores of 1–2) and positive (3–4).

Barriers

As can be seen in Table 2, healthcare professionals did not experience any barriers regarding MULTI_sh itself. Patients identified programme complexity, congruence with the current method (‘the lifestyle treatment fits well with how we aim to work on the ward’) and observability of results as barriers. Of the implementation determinants related to the healthcare professionals and patients themselves, a lack of personal benefits, particularly the negative experience of the time it takes to engage patients and challenges in patient cooperation, was identified as a barrier for healthcare professionals. Task perception (‘I think it is part of my treatment to improve my lifestyle’), the cooperation of the healthcare professionals (how well the nurses implemented MULTI_sh) and awareness of the content of the treatment (almost half of the patients did not recognise the method at all or recognised just a few components) were identified as barriers for patients. Organisational implementation determinants considered barriers by healthcare professionals were formal ratification by management (i.e. limited formal agreements have been made by management about the use of MULTI_sh within the organisation), healthcare professionals’ capacity, financial resources and organisational changes (which were mainly related to insufficient healthcare professionals’ capacity).

Facilitators

All the healthcare professionals believed that MULTI_sh was based on factually correct knowledge, and the majority did not think it was complicated. For patients, there were no facilitators related to MULTI_sh itself. Overall, for implementation determinants related to the user, healthcare professionals responded positively. The vast majority of the determinants were considered to be facilitators, such as outcome expectations, task perception (‘I find working in accordance with MULTI_sh my responsibility’), social support (‘I can count on adequate assistance’), self-efficacy and knowledge (‘I have enough knowledge to be able to use MULTI_sh’). The patients scored MULTI_sh positively on satisfaction and social support, where most help was expected from healthcare professionals (85.7%) and family members (71.4%). The only facilitator identified at the organisational level was having one person coordinate the implementation at each site.

Discussion

The current study aimed to evaluate the effectiveness of MULTI_sh in improving both physical and mental health, as well as whether MULTI_sh was implemented as intended, and to identify associated implementation barriers and facilitators. Owing to the high drop-out in measurements, the study is too underpowered to make any statements on the statistical significance of between-group effects. Nevertheless, no clinically significant changes were seen in either group, and inadequate implementation was observed.

Although evidence on the efficacy of lifestyle interventions for physical health outcomes in SMI is inconsistent,Reference Vancampfort, Firth, Correll, Solmi, Siskind and De Hert9,Reference Speyer, Jakobsen, Westergaard, Nørgaard, Jørgensen and Pisinger43 finding no change in any outcome goes against an emerging body of evidence.Reference Teasdale, Ward, Rosenbaum, Samaras and Stubbs10Reference Stubbs, Vancampfort, Hallgren, Firth, Veronese and Solmi12,Reference Firth, Solmi, Wootton, Vancampfort, Schuch and Hoare24 According to the results on implementation factors, the most likely explanation seems to be inadequate implementation of MULTI_sh, which makes it impossible to make any statements about the effects of MULTI_sh as intended. One-third of the healthcare professionals indicated that, at most, half of them conducted MULTI_sh as intended. Most patients estimated that less than half of the team carried out the programme as intended, and ten patients reported that their daily activity programme did not change and/or they were unfamiliar with the programme description. Also, if MULTI_sh had been implemented to its full extent, one would have expected to observe increases in physical activity and decreases in sedentary behaviour within the MULTI_sh group (e.g.Reference Deenik, Tenback, Tak, Rutters, Hendriksen and van Harten20), as increasing physical activity is one of the critical elements of MULTI_sh. However, no clinically significant improvements in physical activity and sedentary behaviour were observed.

Healthcare professionals indicated that the main implementation barriers were (in)directly linked to organisational factors involving a shortage of healthcare professionals, lack of available time, difficulty getting the patients involved and unfamiliarity with formal agreements made by their management regarding the utility of MULTI_sh. The organisational barriers also correspond with the start of MULTI_sh, as the period between baseline measurement and implementation was longer than intended owing to turnover of healthcare professionals and turbulence within the organisation. This may already have contributed to implementation failure. Previous studies reported that the above-mentioned problems can have a negative impact on the support of lifestyle-related behaviour by mental health nurses and that support from management is essential.Reference Happell, Scott, Nankivell and Platania-Phung44Reference Bartels, Brunette, Aschbrenner and Daumit46 The main barriers experienced by patients match those of healthcare professionals, with their reported complexity of participating in MULTI_sh and a lack of others expecting them to do so. In line with these factors, patients’ illness severity and need for support to overcome difficulties related to their illness were identified as barriers.

Additionally, it appears that difficulties in multidisciplinary cooperation affected the implementation. In contrast to the clinical setting (e.g.Reference Deenik, Tenback, Tak, Rutters, Hendriksen and van Harten20), where activity coordinators, mental health professionals and dietitians were present on site, in the sheltered housing setting these were not part of the regular healthcare professionals’ team. Previously, MULTI in the in-patient setting improved health-related outcomes, although there were many organisational barriers.Reference Deenik, Tenback, Tak, Rutters, Hendriksen and van Harten20Reference Deenik, Tenback, Tak, Blanson Henkemans, Rosenbaum and Hendriksen23 However, the descriptive norm (i.e. how well colleagues implemented MULTI) was perceived to be considerably more positive by both healthcare professionals (81% positive, versus 65% in the current study) and patients (79% v. 38%).Reference Deenik, Tenback, Tak, Blanson Henkemans, Rosenbaum and Hendriksen23 More intensive team cooperation due to the 24 h in-patient care with more staff, including qualified professionals with expertise on lifestyle factors, might have helped them improve despite organisational barriers. However, that study also found that these organisational factors needed to be improved to continue MULTI and to sustain the health benefits.Reference Deenik, Tenback, Tak, Blanson Henkemans, Rosenbaum and Hendriksen23 In the current study, after 12 months of receiving MULTI_sh, there was still little collaboration and contact between some sheltered housing facilities and appropriate social services. Apart from showing how challenging setting up such collaborations in a community setting can be, this also stresses that the teams require support from qualified professionals with expertise in lifestyle factors, as this has been identified several times as being critical to success.Reference Stubbs, Vancampfort, Hallgren, Firth, Veronese and Solmi12,Reference Gilbody, Peckham, Bailey, Arundel, Heron and Crosland47,Reference Teasdale, Latimer, Byron, Schuldt, Pizzinga and Plain48 Therefore, one could argue that the teams should have received more support during implementation to overcome their struggles. However, our study aimed to test the current way of implementation in real-world conditions.

Implications

A crucial facilitating factor identified was that most patients and all healthcare professionals indicated that they believed improving patients’ lifestyle should be part of treatment.

Our findings indicate that intensive implementation strategies, especially at the organisational level, are warranted to successfully implement a multidisciplinary multi-component lifestyle intervention in sheltered housing. An implementation strategy is a method or technique that can stimulate the implementation of an intervention by targeting barriers.Reference Powell, Waltz, Chinman, Damschroder, Smith and Matthieu18 Besides prioritising the topic and addressing healthcare professionals’ capacity and lack of time, integrating professionals qualified to support changing lifestyle behaviour in mental healthcare seems key to helping patients and the existing workforce. Multiple parties are stakeholders in this, such as the management of the mental healthcare organisation itself, their healthcare professionals and patients, the allied health professionals who can support patients and healthcare professionals in making lifestyle changes (in The Netherlands, this support falls within the financial domain of the municipalities) and the health insurance companies (regarding the reimbursement of the professionals needed). For example, a collaborative strategy such as setting up a consortium or coalition with a representation of stakeholders intends to align the perspectives and context of parties and promote development of mutual competence.Reference Powell, Waltz, Chinman, Damschroder, Smith and Matthieu18 This would suit the goal of achieving a more integrative approach, which could help healthcare professionals to take more time with more organisational support to implement MULTI_sh. In turn, this could also help patients to overcome barriers and convert their predominantly positive attitude, recognition and willingness into actual change. Although the above-mentioned barriers seemed key to the failed implementation and are therefore a priority in finding suitable implementation strategies, developing strategies to address other barriers simultaneously (e.g. improving the information about MULTI_sh for patients) can contribute to better implementation. However, to unravel in more detail what strategies are required to improve the implementation of MULTI_sh needs more work. Overall, for organisations who want to improve the lifestyle and poor health of people with SMI, it is essential to be aware that success depends heavily on the priority of the topic within the organisation and the support for staff and patients to enable them to implement it.

Limitations

First, the study was considerably underpowered (i.e. n = 45 in the MULTI_sh group and n = 29 in the TAU, instead of n = 84 each) owing to a high drop-out rate on measurements. This reflects the ongoing challenge of involving patients with SMI in evaluations in real-world settings. To achieve and maintain a larger sample size in such studies, it is vital to keep communicating their relevance and benefit for improving healthcare and to search for methods of measuring that pose the lowest burden on participants to minimise participation refusal. Second, owing to the naturalistic setting of the study and the nature of the intervention, patients were not randomised on an individual level. Also, there might be bias among healthcare professionals regarding the implementation questionnaire, as the least motivated may not have responded, despite the encouragement to participate regardless of attitude towards the topic and intervention, as we aimed to capture the whole spectrum. Third, in the context of comparative tests, it is also worthwhile mentioning that because multiple outcomes were tested, statistical significance may be misleading. However, instead of a binary report of significance versus non-significance, P-values are presented so that the readers can determine the statistical significance according to their standard. In addition, we considered that the magnitude of the effect is more important than statistical significance and that the magnitude of the effect is not affected by multiple testing. Moreover, it would be of value in future studies to include insight into changes in outcomes of personal importance to participants, which may differ from the significance of outcomes measured across the group. This can reveal other favourable outcomes and is essential in the context of engagement. A last possible limitation is that not all the facets that MULTI_sh focuses on can be assessed from our results. For example, we did not study whether the patients’ dietary pattern improved.

Strengths

A notable strength of the study was the controlled design in a naturalistic environment, which was essential to external validity. Other research studying the effects of lifestyle interventions has often been performed under ideal controlled conditions, which are crucial to study efficacy but unlikely to reflect the average level of available time and resources for interventions in daily practice (e.g.Reference Deenik, Czosnek, Teasdale, Stubbs, Firth and Schuch17). The current study represents the routine mental healthcare in sheltered housing facilities, including challenges such as everyday problems, limited available time and turnover of healthcare professionals. In this context, the effectiveness-implementation hybrid design is of added value to gain insight into implementation-related factors and strongly contributes to preventing type 3 error (i.e. rejecting the hypothesis for the wrong reasons), especially in this case of negative findings.

Furthermore, the study sample was representative of daily clinical practice, as patients were included regardless of gender, age or illness severity. The present study contributes to filling the gap between research and practice, by demonstrating the use of methods to improve the external validity to create appropriate evidence which supports decision-making for clinicians and healthcare professionals at management level in real-world settings.Reference Curran, Bauer, Mittman, Pyne and Stetler16,Reference Deenik, Czosnek, Teasdale, Stubbs, Firth and Schuch17,Reference Czosnek, Rankin, Zopf, Richards, Rosenbaum and Cormie49,Reference Lennox, Maher and Reed50

Further research

This study revealed that MULTI_sh was not implemented as intended and that more intensive implementation strategies at an organisational level are warranted. Further studies considering implementation factors in applying lifestyle interventions in sheltered housing are encouraged as the challenge of improving the mental and physical health of people with SMI remains.

Supplementary material

Supplementary material is available online at https://doi.org/10.1192/bjo.2022.600.

Data availability

The data that support the findings of this study are available from the corresponding author on reasonable request.

Author contributions

M.S. and E.d.W.: retrieving, processing and analysing data, drafting and critically reviewing the manuscript. D.T.: study idea, obtaining funding, study design, critical review of the manuscript. J.D.: study idea, obtaining funding, study design, retrieving, processing and analysing data, drafting and critically reviewing the manuscript. All authors gave final approval for the version to be submitted.

Funding

This work was supported by an unrestricted grant from Stichting Zorgondersteuningsfonds.

Declaration of interest

None.

Footnotes

*

Joint first authors.

References

Firth, J, Siddiqi, N, Koyanagi, A, Siskind, D, Rosenbaum, S, Galletly, C, et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry 2019; 6: 675712.CrossRefGoogle ScholarPubMed
Plana-Ripoll, O, Weye, N, Momen, NC, Christensen, MK, Iburg, KM, Laursen, TM, et al. Changes over time in the differential mortality gap in individuals with mental disorders. JAMA Psychiatry 2020; 77: 648–50.CrossRefGoogle ScholarPubMed
Taipale, H, Tanskanen, A, Mehtälä, J, Vattulainen, P, Correll, CU, Tiihonen, J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry 2020; 19: 61–8.CrossRefGoogle Scholar
Mackin, P, Bishop, D, Watkinson, H, Gallagher, P, Ferrier, IN. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br J Psychiatry 2007; 191: 23–9.CrossRefGoogle Scholar
Lopresti, AL, Drummond, PD. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuro-Psychoph 2013; 45: 92–9.CrossRefGoogle ScholarPubMed
Amare, AT, Schubert, KO, Klingler-Hoffmann, M, Cohen-Woods, S, Baune, BT. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiat 2017; 7(1): e1007.CrossRefGoogle ScholarPubMed
Verhaegen, AA, Van Gaal, LF. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options. J Endocrinol Invest 2017; 40: 1165–74.CrossRefGoogle ScholarPubMed
Swildens, W, Termorshuizen, F, de Ridder, A, Smeets, H, Engelhard, IM. Somatic care with a psychotic disorder. lower somatic health care utilization of patients with a psychotic disorder compared to other patient groups and to controls without a psychiatric diagnosis. Adm Policy Ment Hlth 2016; 43: 650–62.CrossRefGoogle ScholarPubMed
Vancampfort, D, Firth, J, Correll, CU, Solmi, M, Siskind, D, De Hert, M, et al. The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019; 18: 5366.CrossRefGoogle ScholarPubMed
Teasdale, SB, Ward, PB, Rosenbaum, S, Samaras, K, Stubbs, B. Solving a weighty problem: systematic review and meta-analysis of nutrition interventions in severe mental illness. Br J Psychiatry 2017; 210(2): 110–8.CrossRefGoogle ScholarPubMed
Czosnek, L, Lederman, O, Cormie, P, Zopf, E, Stubbs, B, Rosenbaum, S. Health benefits, safety and cost of physical activity interventions for mental health conditions: a meta-review to inform translation efforts. Ment Health Phys Act 2019; 16: 140–51.CrossRefGoogle Scholar
Stubbs, B, Vancampfort, D, Hallgren, M, Firth, J, Veronese, N, Solmi, M, et al. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and position statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry 2018; 54: 124–44.CrossRefGoogle Scholar
Taylor, GMJ, Lindson, N, Farley, A, Leinberger-Jabari, A, Sawyer, K, te Water Naudé, R, et al. Smoking cessation for improving mental health. Cochrane Database Syst Rev 2021; 3(3): CD013522.Google ScholarPubMed
Jakobsen, AS, Speyer, H, Norgaard, HCB, Karlsen, M, Birk, M, Hjorthoj, C, et al. Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: two-years follow-up of the randomized CHANGE trial. PLoS One 2017; 12(10): e0185881.Google ScholarPubMed
Naslund, JA, Whiteman, KL, McHugo, GJ, Aschbrenner, KA, Marsch, LA, Bartels, SJ. Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: a systematic review and meta-analysis. Gen Hosp Psychiatry 2017; 47: 83102.Google ScholarPubMed
Curran, GM, Bauer, M, Mittman, B, Pyne, JM, Stetler, C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care 2012; 50: 217–26.CrossRefGoogle ScholarPubMed
Deenik, J, Czosnek, L, Teasdale, SB, Stubbs, B, Firth, J, Schuch, FB, et al. From impact factors to real impact: translating evidence on lifestyle interventions into routine mental health care. Transl Behav Med 2019; 10: 1070–3.CrossRefGoogle Scholar
Powell, BJ, Waltz, TJ, Chinman, MJ, Damschroder, LJ, Smith, JL, Matthieu, MM, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci 2015; 10(1): 21.CrossRefGoogle ScholarPubMed
Deenik, J, Kruisdijk, F, Tenback, D, Braakman-Jansen, A, Taal, E, Hopman-Rock, M, et al. Physical activity and quality of life in long-term hospitalized patients with severe mental illness: a cross-sectional study. BMC Psychiatry 2017; 17(1): 298.CrossRefGoogle ScholarPubMed
Deenik, J, Tenback, DE, Tak, ECPM, Rutters, F, Hendriksen, IJM, van Harten, PN. Changes in physical and psychiatric health after a multidisciplinary lifestyle enhancing treatment for inpatients with severe mental illness: the MULTI study I. Schizophr Res 2019; 204: 360–7.CrossRefGoogle ScholarPubMed
Deenik, J, Tenback, DE, van Driel, HF, Tak, ECPM, Hendriksen, IJM, van Harten, PN. Less medication use in inpatients with severe mental illness receiving a multidisciplinary lifestyle enhancing treatment. the MULTI study III. Front Psychiatry 2018; 9: 707.CrossRefGoogle ScholarPubMed
Deenik, J, Tenback, DE, Tak, ECPM, Hendriksen, IJM, van Harten, PN. Improved psychosocial functioning and quality of life in inpatients with severe mental illness receiving a multidisciplinary lifestyle enhancing treatment. the MULTI study II. Ment Health Phys Act 2018; 15: 145–52.CrossRefGoogle Scholar
Deenik, J, Tenback, DE, Tak, ECPM, Blanson Henkemans, OA, Rosenbaum, S, Hendriksen, IJM, et al. Implementation barriers and facilitators of an integrated multidisciplinary lifestyle enhancing treatment for inpatients with severe mental illness: the MULTI study IV. BMC Health Serv Res 2019; 19: 740.CrossRefGoogle ScholarPubMed
Firth, J, Solmi, M, Wootton, RE, Vancampfort, D, Schuch, FB, Hoare, E, et al. A meta-review of ‘lifestyle psychiatry’: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental illness. World Psychiatry 2020; 19: 360–80.CrossRefGoogle Scholar
Lederman, O, Suetani, S, Stanton, R, Chapman, J, Korman, N, Rosenbaum, S, et al. Embedding exercise interventions as routine mental health care: implementation strategies in residential, inpatient and community settings. Australas Psychiatry 2017; 25: 451–5.CrossRefGoogle ScholarPubMed
Chambers, DA, Norton, WE. The adaptome: advancing the science of intervention adaptation. Am J Prev Med 2016; 51(suppl 2): s124–31.CrossRefGoogle ScholarPubMed
McDevitt, J, Snyder, M, Miller, A, Wilbur, J. Perceptions of barriers and benefits to physical activity among outpatients in psychiatric rehabilitation. J Nurs Scholarsh 2006; 38: 50–5.CrossRefGoogle ScholarPubMed
Kruisdijk, F, Deenik, J, Tenback, D, Tak, E, Beekman, AJ, van Harten, P, et al. Accelerometer-measured sedentary behaviour and physical activity of inpatients with severe mental illness. Psychiat Res 2017; 254: 6774.CrossRefGoogle ScholarPubMed
Jarrett, H, Fitzgerald, L, Routen, AC. Interinstrument reliability of the ActiGraph GT3X+ ambulatory activity monitor during free-living conditions in adults. J Phys Act Health 2015; 12: 382–7.CrossRefGoogle ScholarPubMed
Gatti, AA, Stratford, PW, Brenneman, EC, Maly, MR. GT3X+ accelerometer placement affects the reliability of step-counts measured during running and pedal-revolution counts measured during bicycling. J Sport Sci 2016; 34: 1168–75.CrossRefGoogle ScholarPubMed
Dingemans, PM, Frohndewinter, ML, Bleeker, JAC, Rathod, P. A cross-cultural-study of the reliability and factorial dimensions of the Brief Psychiatric Rating Scale (BPRS). Psychopharmacology 1983; 80: 190–1.CrossRefGoogle Scholar
Kopelowicz, A, Ventura, J, Liberman, RP, Mintz, J. Consistency of brief psychiatric rating scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology 2008; 41: 7784.CrossRefGoogle ScholarPubMed
Williams, A. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199208.Google Scholar
de Vries, J, van Heck, GL. Nederlandse WHOQoL-Bref. Universiteit van Tilburg, 1996.Google Scholar
Konig, HH, Roick, C, Angermeyer, MC. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. Eur Psychiat 2007; 22: 177–87.CrossRefGoogle ScholarPubMed
Pitkanen, A, Valimaki, M, Endicott, J, Katajisto, J, Luukkaala, T, Koivunen, M, et al. Assessing quality of life in patients with schizophrenia in an acute psychiatric setting: reliability, validity and feasibility of the EQ-5D and the Q-LES-Q. Nord J Psychiat 2012; 66: 1925.CrossRefGoogle Scholar
World Health Organization. WHOQOL-Bref: Introduction, Administration, Scoring and Generic Version of the Assessment. Field Trial Version. WHO, 1996.Google Scholar
Trompenaars, F, Masthoff, E, Heck, G, Hodiamont, P, Vries, J. Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients. Qual Life Res 2005; 14: 151–60.CrossRefGoogle Scholar
Herrman, H, Hawthorne, G, Thomas, R. Quality of life assessment in people living with psychosis. Soc Psych Psych Epid 2002; 37: 510–8.CrossRefGoogle ScholarPubMed
Mas-Exposito, L, Amador-Campos, JA, Gomez-Benito, J, Lalucat-Jo, L. The World Health Organization Quality of Life Scale Brief Version: a validation study in patients with schizophrenia. Qual Life Res 2011; 20: 1079–89.CrossRefGoogle ScholarPubMed
Glasgow, RE, Harden, SM, Gaglio, B, Rabin, B, Smith, ML, Porter, GC, et al. RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health 2019; 7: 64.CrossRefGoogle ScholarPubMed
Fleuren, MA, Paulussen, TG, Van Dommelen, P, Van Buuren, S. Towards a measurement instrument for determinants of innovations. Int J Qual Health Care 2014; 26: 501–10.CrossRefGoogle ScholarPubMed
Speyer, H, Jakobsen, AS, Westergaard, C, Nørgaard, HCB, Jørgensen, KB, Pisinger, C, et al. Lifestyle interventions for weight management in people with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects. Psychother Psychosom 2019; 88: 350–62.CrossRefGoogle ScholarPubMed
Happell, B, Scott, D, Nankivell, J, Platania-Phung, C. Screening physical health? Yes! But…: nurses’ views on physical health screening in mental health care. J Clin Nurs 2013; 22: 2286–97.CrossRefGoogle Scholar
Stanton, R, Happell, B, Reaburn, P. Investigating the exercise-prescription practices of nurses working in inpatient mental health settings. Int J Ment Health Nurs 2015; 24: 112–20.CrossRefGoogle ScholarPubMed
Bartels, S, Brunette, M, Aschbrenner, K, Daumit, G. Implementation of a system-wide health promotion intervention to reduce early mortality in high risk adults with serious mental illness and obesity. Implement Sci 2015; 10(suppl 1): A15.Google Scholar
Gilbody, S, Peckham, E, Bailey, D, Arundel, C, Heron, P, Crosland, S, et al. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial. Lancet Psychiatry 2019; 6: 379–90.CrossRefGoogle ScholarPubMed
Teasdale, SB, Latimer, G, Byron, A, Schuldt, V, Pizzinga, J, Plain, J, et al. Expanding collaborative care: integrating the role of dietitians and nutrition interventions in services for people with mental illness. Australas Psychiatry 2018; 26: 47–9.CrossRefGoogle ScholarPubMed
Czosnek, L, Rankin, N, Zopf, E, Richards, J, Rosenbaum, S, Cormie, P. Implementing exercise in healthcare settings: the potential of implementation science. Sports Med 2020; 50: 114.CrossRefGoogle ScholarPubMed
Lennox, L, Maher, L, Reed, J. Navigating the sustainability landscape: a systematic review of sustainability approaches in healthcare. Implement Sci 2018; 13(1): 27.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Flowchart including the number of participants per outcome and reasons for incomplete data on baseline and follow-up.MULTI_sh, multidisciplinary lifestyle-enhancing treatment for people with severe mental illness living in sheltered housing; TAU, treatment as usual; lab, laboratory tests. aFour patients did not receive support by the sheltered housing teams for most of the study time because they were not around (e.g. partly lived elsewhere). bNumber of participants for whom both baseline and follow-up measurements of at least one outcome were available.

Figure 1

Table 1 Baseline characteristics and baseline and follow-up measurements of participants on metabolic health, sedentary behaviour and physical activity, psychopathology and quality of life (n = 74)

Figure 2

Table 2 Participant characteristics and scores for implementation determinants concerning MULTI_sh, healthcare professionals/patients and the organisation, with percentages for negative, neutral and positive responsesa

Supplementary material: PDF

Smit et al. supplementary material

Table S1

Download Smit et al. supplementary material(PDF)
PDF 98.6 KB
Submit a response

eLetters

No eLetters have been published for this article.